Position in LRMR
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,000,444
-$492,736 QoQ
Shares Held
328,015
-1.1% QoQ
Ownership
0.316%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 163 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 80%
Shared 0%
None 20%
Common Shares in LRMR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JPMORGAN CHASE & CO holds $12,940,256,291 across 425 Biotechnology names. LRMR ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,517,600 | $3,237,487,438 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
3,774,199 | $2,353,364,036 | |
| 3 | INSM |
INSMED Inc
|
10,428,170 | $1,111,851,478 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,675,517 | $805,410,876 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
3,298,066 | $617,661,794 | |
| 6 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
2,652,746 | $294,534,385 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
1,160,786 | $279,714,596 | |
| 8 | QURE |
uniQure N.V.
|
4,867,755 | $224,208,791 |
All Filings in LRMR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,000,444 | 328,015 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,493,180 | 331,818 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $94,731 | 24,864 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $81,592 | 25,261 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $160,821 | 55,648 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $138,926 | 64,617 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $94,628 | 24,452 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $142,599 | 21,771 | Shares | Defined | 2024-12-26 | |
| 2024-06-30 | $133,008 | 18,346 | Shares | Defined | 2024-12-26 | |
| 2024-03-31 | $902,351 | 118,887 | Shares | Defined | 2024-12-26 | |
| 2023-12-31 | $275,283 | 60,502 | Shares | Defined | 2024-12-26 | |
| 2023-09-30 | $109,449 | 27,709 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $194,074 | 62,005 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $3,043,511 | 671,857 | Shares | Defined | 2023-05-18 | |
| 2022-12-31 | $183,299 | 44,790 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $3,603 | 1,126 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,927 | 2,004 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $8,509 | 2,101 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $17,026 | 1,578 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $12,821 | 1,112 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $7,374 | 751 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $175 | 12 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $256 | 12 | Shares | Defined | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||